Ezurpimtrostat hydrochloride (compound 2-3) is a potent and orally active anti-fibrotic agent. It significantly reduces liver fibrosis in DEN (diethyl nitrosamine) cirrhotic rat models, and can be utilized for research related to fibrosis, cancer, autophagy, and diseases involving cathepsins B (CTSB), L (CTSL), and D (CTSD).
- Potent and orally active anti-fibrotic agent.
- Significantly reduces liver fibrosis in DEN cirrhotic rat models.
- Applicable for research in fibrosis, cancer, autophagy, and cathepsins B, L, and D related diseases.
- Purity of 99.29%.